Literature DB >> 6997311

Fibroblastic cultures from the diabetic db/db mouse. Demonstration of decreased insulin receptors and impaired responses to insulin.

M K Raizada, G Tan, R E Fellows.   

Abstract

Binding of 125I-insulin to cells cultured from the skin of nondiabetic and diabetic (db/db) mice was 80 to 90% specific, time- and temperature-dependent, and maximal at pH 8.0. Porcine insulin and desalanine insulin competed equally for 125I-insulin binding, while proinsulin and desoctapeptide insulin were 35% and 20% as potent, respectively. 125I-Insulin dissociated from both types of fibroblasts with a T 1/2 of 7.5 min. Analysis of the dissociation data resolved two rate constants of 3.0 and 1.0 X 10(-4) s-1 for nondiabetic, and 2.0 and 0.8 X 10(-4) s-1 for diabetic fibroblasts. Binding of 125I-insulin to diabetic fibroblasts was 35 to 50% of that to nondiabetic fibroblasts during at least 17 passages. Scatchard analysis of the binding data resolved high (K1 = 2 X 10(10( M-1) and low affinity K2 = 2 X 10(9) M-1) sites. Nondiabetic fibroblasts possessed 7.7 X 10(4) sites/cell, while diabetic fibroblasts possessed 2.9 X 10(4)/cell. Incubation of nondiabetic fibroblasts with insulin resulted in a time- and concentration-dependent decrease in the binding of 125I-insulin. Binding activity returned to normal when insulin was removed and it was prevented by cycloheximide. In contrast, diabetic fibroblasts did not exhibit down-regulation of receptors. A half-maximal and maximum (85%) stimulation of 2 deoxy-D-glucose uptake was observed with 0.75 nM and 16.7 nM insulin in nondiabetic fibroblasts. In contrast, diabetic cultures required 3.5 nM insulin for half-maximal stimulation of 2 deoxy-D-glucose uptake, and maximum stimulation was 32% with 16.7 nM insulin. Similarly, diabetic fibroblasts required higher concentrations of insulin (20 nM) to stimulate ornithine decarboxylase activity to 42% of nondiabetic cells. These results indicate that in comparison with fibroblastic cultures from nondiabetic animals, those from diabetic animals expressed differences in insulin receptor numbers which are maintained in culture over many generations and are accompanied by diminished insulin responses.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6997311

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Analysis of interaction between insulin binding and insulin effect on primary culture of normal and db/db mouse hepatocytes.

Authors:  T Ueno; S Ozaki
Journal:  Gastroenterol Jpn       Date:  1990-06

2.  Insulin effect on GABA uptake in astroglial primary cultures.

Authors:  K Bouhaddi; P Thomopoulos; C Fages; M Khelil; M Tardy
Journal:  Neurochem Res       Date:  1988-12       Impact factor: 3.996

3.  Identification of persistent defects in insulin receptor structure and function capillary endothelial cells from diabetic rats.

Authors:  C F Kwok; B J Goldstein; D Muller-Wieland; T S Lee; C R Kahn; G L King
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

4.  Insulin binding and activation of glycogen synthase in fibroblasts from Type 1 (insulin-dependent) diabetic patients.

Authors:  J M Podskalny; C R Kahn
Journal:  Diabetologia       Date:  1982-11       Impact factor: 10.122

5.  Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding.

Authors:  J D Laskin; E Lee; D L Laskin; M A Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

6.  Insulin binding in cultured Chinese hamster kidney epithelial cells: the effect of serum in the medium.

Authors:  B M Wyse; A Y Chang
Journal:  In Vitro       Date:  1982-03

Review 7.  Cellular Senescence as the Pathogenic Hub of Diabetes-Related Wound Chronicity.

Authors:  Jorge A Berlanga-Acosta; Gerardo E Guillén-Nieto; Nadia Rodríguez-Rodríguez; Yssel Mendoza-Mari; Maria Luisa Bringas-Vega; Jorge O Berlanga-Saez; Diana García Del Barco Herrera; Indira Martinez-Jimenez; Sandra Hernandez-Gutierrez; Pedro A Valdés-Sosa
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-16       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.